Molecular Mechanism of SLC5A8 Inactivation in Breast Cancer

ABSTRACT SLC5A8 is a putative tumor suppressor that is inactivated in more than 10 different types of cancer, but neither the oncogenic signaling responsible for SLC5A8 inactivation nor the functional relevance of SLC5A8 loss to tumor growth has been elucidated. Here, we identify oncogenic HRAS (HRASG12V) as a potent mediator of SLC5A8 silencing in human nontransformed normal mammary epithelial cell lines and in mouse mammary tumors through DNMT1. Further, we demonstrate that loss of Slc5a8 increases cancer-initiating stem cell formation and promotes mammary tumorigenesis and lung metastasis in an HRAS-driven murine model of mammary tumors. Mammary-gland-specific overexpression of Slc5a8 (mouse mammary tumor virus-Slc5a8 transgenic mice), as well as induction of endogenous Slc5a8 in mice with inhibitors of DNA methylation, protects against HRAS-driven mammary tumors. Collectively, our results provide the tumor-suppressive role of SLC5A8 and identify the oncogenic HRAS as a mediator of tumor-associated silencing of this tumor suppressor in mammary glands. These findings suggest that pharmacological approaches to reactivate SLC5A8 expression in tumor cells have potential as a novel therapeutic strategy for breast cancer treatment.

[1]  Philippe Sansonetti,et al.  Microbial-gut interactions in health and disease. Epithelial cell responses. , 2004, Best practice & research. Clinical gastroenterology.

[2]  G. Cresci,et al.  Sodium-Coupled Transport of the Short Chain Fatty Acid Butyrate by SLC5A8 and Its Relevance to Colon Cancer , 2008, Journal of Gastrointestinal Surgery.

[3]  Rudolf Jaenisch,et al.  Targeted mutation of the DNA methyltransferase gene results in embryonic lethality , 1992, Cell.

[4]  L. Altucci,et al.  Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells , 2005, Nature Medicine.

[5]  E. Liu,et al.  Inhibitors of histone deacetylases target the Rb-E2F1 pathway for apoptosis induction through activation of proapoptotic protein Bim. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[6]  J. Davie.  Inhibition of histone deacetylase activity by butyrate. , 2003, The Journal of nutrition.

[7]  G. Del Sal,et al.  Evidence of enhancement of the ras oncogene protein product (p21) in a spectrum of human tumors , 1989, International journal of cancer.

[8]  M. Szyf,et al.  DNA Methyltransferase Is a Downstream Effector of Cellular Transformation Triggered by Simian Virus 40 Large T Antigen* , 1999, The Journal of Biological Chemistry.

[9]  M. Baccarini.  An old kinase on a new path: Raf and apoptosis , 2002, Cell Death and Differentiation.

[10]  M. Szyf,et al.  Regulation of the DNA Methyltransferase by the Ras-AP-1 Signaling Pathway (*) , 1995, The Journal of Biological Chemistry.

[11]  K. Schuebel,et al.  CIMPle origin for promoter hypermethylation in colorectal cancer? , 2006, Nature Genetics.

[12]  F. Borson‐Chazot,et al.  0021-972X/05/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 90(5):3028–3035 Printed in U.S.A. Copyright © 2005 by The Endocrine Society doi: 10.1210/jc.2004-1394 Silencing of the Tumor Suppressor Gene SLC5A8 Is Associated with BRAF Mutations , 2022 .

[13]  M. Szyf,et al.  Transcriptional regulation of the human DNA Methyltransferase (dnmt1) gene. , 2000, Gene.

[14]  N. Matsubara,et al.  Colorectal cancer with mutation in BRAF, KRAS, and wild-type with respect to both oncogenes showing different patterns of DNA methylation. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  M. Szyf,et al.  A Conserved 3′-Untranslated Element Mediates Growth Regulation of DNA Methyltransferase 1 and Inhibits Its Transforming Activity* , 2001, The Journal of Biological Chemistry.

[16]  L. Wakefield,et al.  TGF-beta switches from tumor suppressor to prometastatic factor in a model of breast cancer progression. , 2003, The Journal of clinical investigation.

[17]  J. L. Bos,et al.  ras oncogenes in human cancer: a review. , 1989, Cancer research.

[18]  P. Hand,et al.  Quantitation of Harvey ras p21 enhanced expression in human breast and colon carcinomas. , 1987, Journal of the National Cancer Institute.

[19]  R. Weinberg,et al.  Suppression of intestinal neoplasia by DNA hypomethylation , 1995, Cell.

[20]  P. Hand,et al.  Expression of the 21,000 molecular weight ras protein in a spectrum of benign and malignant human mammary tissues. , 1986, Cancer research.

[21]  M. Barbacid,et al.  Direct mutagenesis of Ha-ras-1 oncogenes by N-nitroso-N-methylurea during initiation of mammary carcinogenesis in rats , 1985, Nature.

[22]  L. Wakefield,et al.  TGF-β switches from tumor suppressor to prometastatic factor in a model of breast cancer progression , 2003 .

[23]  V. Ganapathy,et al.  Sodium-coupled and electrogenic transport of B-complex vitamin nicotinic acid by slc5a8, a member of the Na/glucose co-transporter gene family. , 2005, The Biochemical journal.

[24]  D. Spandidos,et al.  Human malignant tumours of the breast, as compared to their respective normal tissue, have elevated expression of the Harvey ras oncogene. , 1984, Anticancer research.

[25]  P. Jones,et al.  DNA methyltransferase levels in tumorigenic and nontumorigenic cells in culture. , 1986, The Journal of biological chemistry.

[26]  V. Ganapathy,et al.  Transport of Nicotinate and Structurally Related Compounds by Human SMCT1 (SLC5A8) and Its Relevance to Drug Transport in the Mammalian Intestinal Tract , 2007, Pharmaceutical Research.

[27]  D. Sabatini,et al.  MCT1-mediated transport of a toxic molecule is an effective strategy for targeting glycolytic tumors , 2012, Nature Genetics.

[28]  T. Shiraishi,et al.  Histone deacetylase inhibitors upregulate death receptor 5/TRAIL-R2 and sensitize apoptosis induced by TRAIL/APO2-L in human malignant tumor cells , 2004, Oncogene.

[29]  T. Boettger,et al.  Lactaturia and Loss of Sodium-dependent Lactate Uptake in the Colon of SLC5A8-deficient Mice* , 2008, Journal of Biological Chemistry.

[30]  V. Ganapathy,et al.  Sodium-coupled Monocarboxylate Transporters in Normal Tissues and in Cancer , 2008, The AAPS Journal.

[31]  T. Curran,et al.  Role of DNA 5-methylcytosine transferase in cell transformation by fos. , 1999, Science.

[32]  R. Cardiff,et al.  Specific activation of the cellular Harvey-ras oncogene in dimethylbenzanthracene-induced mouse mammary tumors , 1986, Molecular and cellular biology.

[33]  R. DePinho,et al.  Pancreatic cancer biology and genetics , 2002, Nature Reviews Cancer.

[34]  V. Ganapathy,et al.  Identity of SMCT1 (SLC5A8) as a neuron‐specific Na+‐coupled transporter for active uptake of l‐lactate and ketone bodies in the brain , 2006, Journal of neurochemistry.

[35]  Fred R. Miller,et al.  Malignant MCF10CA1 Cell Lines Derived from Premalignant Human Breast Epithelial MCF10AT Cells , 2004, Breast Cancer Research and Treatment.

[36]  J. Herman,et al.  Expression of an exogenous eukaryotic DNA methyltransferase gene induces transformation of NIH 3T3 cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[37]  V. Ganapathy,et al.  SLC5A8 triggers tumor cell apoptosis through pyruvate-dependent inhibition of histone deacetylases. , 2006, Cancer research.

[38]  V. Ganapathy,et al.  Functional Identification of SLC5A8, a Tumor Suppressor Down-regulated in Colon Cancer, as a Na+-coupled Transporter for Short-chain Fatty Acids* , 2004, Journal of Biological Chemistry.

[39]  H. Herzel,et al.  Oncogenic HRAS suppresses clusterin expression through promoter hypermethylation , 2006, Oncogene.

[40]  E. Passegué.  Cancer biology: A game of subversion , 2006, Nature.

[41]  Peter A. Jones,et al.  The Epigenomics of Cancer , 2007, Cell.

[42]  V. Ganapathy,et al.  Expression of slc5a8 in Kidney and Its Role in Na+-coupled Transport of Lactate* , 2004, Journal of Biological Chemistry.

[43]  Gong Yang,et al.  Silencing of H-ras gene expression by retrovirus-mediated siRNA decreases transformation efficiency and tumorgrowth in a model of human ovarian cancer , 2003, Oncogene.

[44]  S. Baylin,et al.  Increased cytosine DNA-methyltransferase activity is target-cell-specific and an early event in lung cancer. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[45]  C. Plass,et al.  SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[46]  F. Arvelo,et al.  [Stem cells and cancer]. , 2014, Investigacion clinica.

[47]  V. Ganapathy,et al.  Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond. , 2009, Pharmacology & therapeutics.

[48]  F. Miller,et al.  MCF10AT: a model for the evolution of cancer from proliferative breast disease. , 1996, The American journal of pathology.

[49]  V. Ganapathy,et al.  Colon cancer cells maintain low levels of pyruvate to avoid cell death caused by inhibition of HDAC1/HDAC3. , 2009, The Biochemical journal.

[50]  M. Szyf,et al.  Regulation of DNA methylation by the Ras signaling pathway , 1995, The Journal of Biological Chemistry.

[51]  V. Ganapathy,et al.  SLC5A8 (SMCT1)-mediated transport of butyrate forms the basis for the tumor suppressive function of the transporter. , 2006, Life sciences.

[52]  C. Peyssonnaux,et al.  The Raf/MEK/ERK pathway: new concepts of activation , 2001, Biology of the cell.

[53]  Peter A. Jones,et al.  The fundamental role of epigenetic events in cancer , 2002, Nature Reviews Genetics.

[54]  T. S. Manning,et al.  Microbial-gut interactions in health and disease. Prebiotics. , 2004, Best practice & research. Clinical gastroenterology.

[55]  M. Szyf.  DNA methylation patterns: an additional level of information? , 1991, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[56]  Lucia Altucci,et al.  Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway , 2005, Nature Medicine.

[57]  K. Kinzler,et al.  Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status , 2002, Nature.

[58]  V. Ganapathy,et al.  c/ebpδ Null Mouse as a Model for the Double Knock-out of slc5a8 and slc5a12 in Kidney* , 2006, Journal of Biological Chemistry.

[59]  S. Baylin,et al.  High expression of the DNA methyltransferase gene characterizes human neoplastic cells and progression stages of colon cancer. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[60]  T. Kouzarides.  Chromatin Modifications and Their Function , 2007, Cell.

[61]  M. Romero,et al.  The human tumour suppressor gene SLC5A8 expresses a Na+–monocarboxylate cotransporter , 2004, The Journal of physiology.

[62]  A. Nicholson,et al.  Mutations of the BRAF gene in human cancer , 2002, Nature.